Aurobindo Pharma has informed that an Analyst / investor call on the Unaudited Financial Results for the quarter and nine months ended December 31, 2015 is scheduled on February 10, 2016 at 17:30 hrs.
The above information is a part of company’s filings submitted to BSE.